Combining statins with amlodipine to treat primary aldosteronism
Official title: A Prospective, Multi-center, Randomized Trial to Compare Statin Combined with CCB to MRA Combined with CCB in Primary Aldosteronism Treatment
Run by Third Military Medical University · NCT06523465 · Data updated 2026-11-12
This study is testing if combining statins with amlodipine can help people with primary aldosteronism manage their condition better.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Third Military Medical University Academic / other |
| Locations | 1 site (Chongqing, Chongqing Municipality) |
| Status | Recruiting |
| Started | September 10, 2024 |
| Main results expected | December 30, 2025 |
| Study ends | September 30, 2026 |
| Registry record updated | November 22, 2024 |
| Trial ID | NCT06523465 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with primary aldosteronism.
✕Probably not a fit
Patients with allergies to the study drugs, pregnancy, severe liver or kidney dysfunction, or mental illness may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of combining statins with amlodipine in treating patients with primary aldosteronism. Participants will be randomly assigned to one of three treatment groups: one receiving statin and amlodipine, another receiving statin, spironolactone, and amlodipine, and the last receiving amlodipine and spironolactone. The study will monitor changes in plasma aldosterone levels, 24-hour urinary aldosterone, blood pressure, and long-term cardiovascular risks associated with these treatments.
Why it matters
Potential benefit: If successful, this study could improve treatment options and cardiovascular outcomes for patients with primary aldosteronism.
How similar studies have gone: While there is limited information on similar studies, the combination of these medications has shown promise in managing hypertension and related conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of primary aldosteronism Exclusion Criteria: * Allergy to drugs in this study * Pregnancy * Severe liver and kidney dysfunction * Mental illness
Where it's running
-
No. 10 Changjiang River Branch, Yuzhong District,Chongqing, China
Chongqing, Chongqing Municipality, China Recruiting
Study contacts
- Study coordinator: sun fang
- Email: sun_fang2007@163.com
- Phone: +862368729587
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Spironolactone with antihypertensives for unilateral primary aldosteronism
This project will try different doses of spironolactone together with usual blood-pressure medicines in adults with lateralized primary aldosteronism who decline surgery to see if it relieves renin suppression and lowers long-term cardiovascular risks.
-
Screening for Primary Aldosteronism using Steroids
This study is testing a new steroid-based method to see if it can better identify Primary Aldosteronism in people with high blood pressure who are taking their usual medications.
-
Improving screening for primary aldosteronism in patients with hypertension
This study is testing if giving a small dose of dexamethasone can help doctors better identify primary aldosteronism in patients with high blood pressure who are already on medication.
-
Quantifying sodium levels in muscles of patients with primary aldosteronism
This study is testing a new way to measure sodium levels in the muscles of people with primary aldosteronism to see if it helps improve understanding and treatment of the condition.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Impact of Aldosterone Blockade on Heart Function in Primary Aldosteronism
This study is testing if a medication that blocks a hormone called aldosterone can improve heart function in people with primary aldosteronism, which causes high blood pressure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.